Legal Information
document
November 7, 2019 — 00:00
4080
-
-
NewsNovember 5, 2019
SCOR Global Life has made a strategic investment in BioSerenity, a French medical solutions company that aims to optimize the patient pathways in several chronic diseases through the design of connected devices, end-t
-
This publication presents some global information on kidney diseases, the definitions and basic notions, protective treatments, renal replacement therapies, disease progression information as well as proposed underwri
documentNovember 4, 2019 — 00:00 -
News
October 28, 2019
In order to achieve the objectives of the “Quantum Leap” strategic plan, SCOR Global Life evolves its organisation and announces promotions in its Global Markets team.
-
Press ReleasesFirst Nine Months 2019 Results
-
First Nine Months 2019 Results
documentOctober 24, 2019 — 00:00 -
SCOR delivers a solid performance with net income of EUR 401 million in the first nine months of 2019
documentOctober 24, 2019 — 00:00 -
A weather analysis of China’s agricultural production risk.
documentOctober 15, 2019 — 00:00 -
Legal information
documentOctober 10, 2019 — 00:00 -
SOLEM supports our clients throughout the world to assess risks, including a dedicated Claims management section.
documentOctober 9, 2019 — 00:00 -
-
Press ReleasesA.M. Best has decided to affirm SCOR’s Financial Strength Rating of ‘A+ (Superior)’ and its Long-Term Issuer Credit Ratings of ‘aa-’.
